Medical treatment of Benign Prostatic Hyperplasia [Porena - Minerva Medica]
- ISBN/EAN
- 9788877118738
- Editore
- Minerva Medica
- Formato
- Brossura
- Anno
- 2016
- Pagine
- 112
Disponibile
28,00 €
The medical therapy for benign prostatic hyperplasia has a short history, which started no farther back than 25-30 years ago. Before then, surgery was the only real treatment for prostatic disease aimed at also resolving the associated lower urinary tract symptoms (LUTS).
Nowadays, several drugs are available for the treatment of prostatic enlargement, which stop or minimize glandular growth, improve bladder neck and urethral hypertonicity or reduce the associated LUTS. They can be used as a monotherapy or in various combinations.
This book is meant to be a summary of the latest developments in the management of benign prostatic hyperplasia and a guide to the use of drugs, focusing on their biological mechanisms of action and their adverse events. The Authors involved in this work are the back-bone of research in this field in Italy. Therefore this is an indispensable reference book useful to fellows and specialists in urology.
Maggiori Informazioni
| Autore | Porena Massimo |
|---|---|
| Editore | Minerva Medica |
| Anno | 2016 |
| Tipologia | Libro |
| Lingua | Inglese |
| Indice | ETIOPATHOGENETIC AND PATHOPHYSIOLOGIC PATHWAYS Ethiopathogenesis Pathophysiology of benign prostatic obstruction Bladder and prostatic urethra innervation CLINICAL ENDPOINTS OF MEDICAL TREATMENT, INDICATIONS AND PATIENT SELECTION Indications and patient selection Clinical endpoints MEDICAL TREATMENT α1-blockers α1-blockers Androgen manipulation: 5-α-reductase inhibitors, other antiandrogens, aromatase inhibitors (antiestrogens) 5-α-reductase inhibitors Other androgen manipulations Treatment of symptoms related to BPH: anticholinergics (antimuscarinics), phosphodiesterase-5 inhibitors, β3-agonists Muscarinic receptor antagonists Phosphodiesterase type 5 inhibitors Combination therapy in BPH Therapy with α-adrenergic blockers Androgen manipulation Combination therapy with α blocker and 5-α-reductase inhibitor Anticholinergic (antimuscarinic) receptor blockers Phosphodiesterase inhibitors Phytotherapy and nutraceuticals Pygeum africanum Hypoxis hemerocallidea Cucurbita pepo Epilobium spp. Lycopersicum esculentum Pinus pinaster Roystonea regia Secale cereale Urtica dioica Serenoa repens Conclusions |
Questo libro è anche in: